Docteur Julien BRAUX

Delion, M ; Braux, J ; Jourdain, ML ; Guillaume, C ; Bour, C ; Gangloff, S & al; Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis. J. Pathol. 2016, 240:50-60; IF (7,381), Rang A.
Jacquot, J ; Delion, M ; Gangloff, S ; Braux, J ; Velard, F; Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies. Osteoporos Int. 2016, 27:1401-12; IF3,445, Rang C.

Velard, F ; Braux, J ; Amedee, J ; Laquerriere, P; Inflammatory cell response to calcium phosphate biomaterial particles: an overview. 2013; 9:4956-63; IF:5,684, Rang A.

Braux, J ; Velard, F ; Guillaume, C ; Bouthors, S ; Jallot, E ; Nedelec, JM & al; A new insight into the dissociating effect of strontium on bone resorption and formation. Acta Biomater; 2011; 7: 2593-603; IF:4,865, Rang A.

Le Heron, L ; Guillaume, C ; Velard, F ; Braux, J ; Touqui, L ; Moriceau, S & al. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.J. Cyst. Fibros. 2010, 9:69-72; IF:2,84; Rang C.

Velard, F ; Laurent-Maquin, D ; Braux, J ; Guillaume, C ; Bouthors, S ; Jallot, E & al. The effect of zinc on hydroxyapatite-mediated activation of human polymorphonuclear neutrophils and bone implant-associated acute inflammation. Biomaterials, 2010, 31: 2001-9, IF:2001-9; Rang A.

Braux, J; Velard, F; Guillaume, C; Jourdain, ML; Gangloff, SC; Jallot, E; Nedelec, JM; Laquerrière, P; Laurent-Maquin, D. Strontium-Substituted Bioceramics Particles: A New Way to Modulate MCP-1 and Gro-a Production by Human Primary Osteoblastic Cells, Materials 2016; 9(12) 938-990; IF:2,728; Rang B